Latin America Adalimumab Market is Expected to Reach US$1.18 bn by 2023

Latin America Adalimumab Market was valued at US$994.8 mn in 2014 and is expected to reach US$1,186.4 mn by 2023, at a CAGR of 0.4% during the forecast period from 2015 to 2023.
http://bit.ly/1JUznXD